Total Payments
$34,288
2024 Payments
$3,001
Companies
11
Transactions
83
Medicare Patients
190
Medicare Billing
$29,936
Payment Breakdown by Category
Other$28,500 (83.1%)
Travel$3,245 (9.5%)
Food & Beverage$2,543 (7.4%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Honoraria | $28,500 | 15 | 83.1% |
| Travel and Lodging | $3,245 | 9 | 9.5% |
| Food and Beverage | $2,543 | 59 | 7.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Fresenius USA Marketing, Inc. | $32,770 | 57 | $0 (2024) |
| Amgen Inc. | $383.78 | 9 | $0 (2022) |
| AstraZeneca Pharmaceuticals LP | $320.72 | 7 | $0 (2023) |
| Travere Therapeutics, Inc. | $187.62 | 2 | $0 (2024) |
| Horizon Therapeutics plc | $122.51 | 1 | $0 (2021) |
| GENZYME CORPORATION | $119.08 | 1 | $0 (2024) |
| Alnylam Pharmaceuticals Inc. | $92.79 | 2 | $0 (2024) |
| Alexion Pharmaceuticals, Inc. | $88.51 | 1 | $0 (2024) |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | $82.22 | 1 | $0 (2024) |
| Vifor Pharma, Inc. | $67.49 | 1 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $3,001 | 12 | Fresenius USA Marketing, Inc. ($2,604) |
| 2023 | $6,261 | 15 | Fresenius USA Marketing, Inc. ($6,071) |
| 2022 | $24,450 | 40 | Fresenius USA Marketing, Inc. ($24,012) |
| 2021 | $576.05 | 16 | Amgen Inc. ($194.96) |
All Payment Transactions
83 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/24/2024 | GENZYME CORPORATION | FABRAZYME (Biological) | Food and Beverage | In-kind items and services | $119.08 | General |
| Category: Genetic Disease | ||||||
| 10/16/2024 | Fresenius USA Marketing, Inc. | Velphoro (Drug) | Food and Beverage | In-kind items and services | $14.48 | General |
| Category: Phosphate binder for ESRD | ||||||
| 09/03/2024 | Fresenius USA Marketing, Inc. | Velphoro (Drug) | Food and Beverage | In-kind items and services | $7.77 | General |
| Category: Phosphate binder for ESRD | ||||||
| 08/15/2024 | Alnylam Pharmaceuticals Inc. | OXLUMO (Drug) | Food and Beverage | In-kind items and services | $45.18 | General |
| Category: Genetic Disease | ||||||
| 08/14/2024 | Fresenius USA Marketing, Inc. | Velphoro (Drug) | Honoraria | Cash or cash equivalent | $2,000.00 | General |
| Category: Phosphate binder for ESRD | ||||||
| 08/06/2024 | Fresenius USA Marketing, Inc. | Velphoro (Drug) | Food and Beverage | Cash or cash equivalent | $50.00 | General |
| Category: Phosphate binder for ESRD | ||||||
| 07/23/2024 | Fresenius USA Marketing, Inc. | Velphoro (Drug) | Honoraria | Cash or cash equivalent | $500.00 | General |
| Category: Phosphate binder for ESRD | ||||||
| 05/23/2024 | Alexion Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $88.51 | General |
| 05/08/2024 | Fresenius USA Marketing, Inc. | — | Food and Beverage | In-kind items and services | $13.79 | General |
| 04/30/2024 | Otsuka Pharmaceutical Development & Commercialization, Inc. | — | Food and Beverage | In-kind items and services | $82.22 | General |
| 03/26/2024 | Fresenius USA Marketing, Inc. | — | Food and Beverage | In-kind items and services | $17.48 | General |
| 02/22/2024 | Travere Therapeutics, Inc. | — | Food and Beverage | In-kind items and services | $62.68 | General |
| 12/06/2023 | Fresenius USA Marketing, Inc. | — | Food and Beverage | In-kind items and services | $7.21 | General |
| 11/08/2023 | Fresenius USA Marketing, Inc. | Velphoro (Drug) | Travel and Lodging | Cash or cash equivalent | $569.85 | General |
| Category: Phosphate binder for ESRD | ||||||
| 11/01/2023 | Fresenius USA Marketing, Inc. | Velphoro (Drug) | Honoraria | Cash or cash equivalent | $2,000.00 | General |
| Category: Phosphate binder for ESRD | ||||||
| 10/25/2023 | Fresenius USA Marketing, Inc. | Velphoro (Drug) | Travel and Lodging | Cash or cash equivalent | $750.00 | General |
| Category: Phosphate binder for ESRD | ||||||
| 10/25/2023 | Fresenius USA Marketing, Inc. | Velphoro (Drug) | Travel and Lodging | Cash or cash equivalent | $540.40 | General |
| Category: Phosphate binder for ESRD | ||||||
| 10/25/2023 | Fresenius USA Marketing, Inc. | Velphoro (Drug) | Food and Beverage | In-kind items and services | $120.73 | General |
| Category: Phosphate binder for ESRD | ||||||
| 09/26/2023 | Travere Therapeutics, Inc. | — | Food and Beverage | In-kind items and services | $124.94 | General |
| 08/29/2023 | Fresenius USA Marketing, Inc. | Velphoro (Drug), KORSUVA | Food and Beverage | In-kind items and services | $6.36 | General |
| Category: Phosphate binder for ESRD | ||||||
| 08/10/2023 | Alnylam Pharmaceuticals Inc. | OXLUMO (Drug) | Food and Beverage | In-kind items and services | $47.61 | General |
| Category: Genetic Disease | ||||||
| 07/10/2023 | Fresenius USA Marketing, Inc. | — | Food and Beverage | In-kind items and services | $18.61 | General |
| 06/07/2023 | Fresenius USA Marketing, Inc. | Velphoro (Drug) | Honoraria | Cash or cash equivalent | $2,000.00 | General |
| Category: Phosphate binder for ESRD | ||||||
| 05/22/2023 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $17.81 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 05/10/2023 | Fresenius USA Marketing, Inc. | Velphoro (Drug) | Food and Beverage | In-kind items and services | $20.40 | General |
| Category: Phosphate binder for ESRD | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 4 | 127 | 138 | $36,453 | $8,576 |
| 2022 | 1 | 18 | 31 | $21,517 | $5,850 |
| 2021 | 1 | 19 | 37 | $25,682 | $6,944 |
| 2020 | 1 | 26 | 56 | $38,870 | $8,567 |
Total Patients
190
Total Services
262
Medicare Billing
$29,936
Procedure Codes
7
All Medicare Procedures & Services
7 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 90961 | Dialysis services, 2-3 physician visits per month (20 years or older) | Office | 2023 | 14 | 25 | $17,353 | $4,612 | 26.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 67 | 67 | $10,720 | $2,428 | 22.7% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 27 | 27 | $6,480 | $1,111 | 17.1% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 19 | 19 | $1,900 | $424.68 | 22.4% |
| 90961 | Dialysis services, 2-3 physician visits per month (20 years or older) | Office | 2022 | 18 | 31 | $21,517 | $5,850 | 27.2% |
| 90961 | Dialysis services (2-3 physician visits per month), patient 20 years of age and older | Office | 2021 | 19 | 37 | $25,682 | $6,944 | 27.0% |
| 90961 | Dialysis services (2-3 physician visits per month), patient 20 years of age and older | Office | 2020 | 26 | 56 | $38,870 | $8,567 | 22.0% |
About Angela Craig, APRN
Angela Craig, APRN is a Registered Nurse healthcare provider based in Omaha, Nebraska. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/17/2019. The National Provider Identifier (NPI) number assigned to this provider is 1013567403.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Angela Craig, APRN has received a total of $34,288 in payments from pharmaceutical and medical device companies, with $3,001 received in 2024. These payments were reported across 83 transactions from 11 companies. The most common payment nature is "Honoraria" ($28,500).
As a Medicare-enrolled provider, Craig has provided services to 190 Medicare beneficiaries, totaling 262 services with total Medicare billing of $29,936. Data is available for 4 years (2020–2023), covering 7 distinct procedure/service records.
Ad
Practice Information
- Specialty Registered Nurse
- Other Specialties Nurse Practitioner, Family
- Location Omaha, NE
- Active Since 09/17/2019
- Last Updated 11/28/2023
- Taxonomy Code 163W00000X
- Entity Type Individual
- NPI Number 1013567403
Products in Payments
- Velphoro (Drug) $32,713
- Parsabiv (Drug) $383.78
- LOKELMA (Drug) $154.75
- FARXIGA (Drug) $142.81
- KRYSTEXXA (Biological) $122.51
- FABRAZYME (Biological) $119.08
- OXLUMO (Drug) $92.79
- Sedline (Device) $53.70
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Registered Nurse Doctors in Omaha
Jasper Kaufman, Aprn, APRN
Registered Nurse — Payments: $8,208
Registered Nurse $8,208
Margaret Wallace, Aprn, APRN
Registered Nurse — Payments: $5,778
Registered Nurse $5,778
Rise Mitchell, Dnp, Aprn, Pmhnp-Bc, DNP, APRN, PMHNP-BC
Registered Nurse — Payments: $4,373
Registered Nurse $4,373
Rebecca Andresen, Rn, RN
Registered Nurse — Payments: $4,162
Registered Nurse $4,162
Karen Betjacob, Aprn, APRN
Registered Nurse — Payments: $3,550
Registered Nurse $3,550
Megan Scott, Aprn, APRN
Registered Nurse — Payments: $3,299
Registered Nurse $3,299